tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Hazlett, 65 are a BUY (89.04%), 7 are a HOLD (9.59%), 1 are a SELL (1.37%).
Analyst Robert Hazlett, carries an average stock price target met ratio of 34.17% that have a potential upside of 48.46% achieved within 179 days. Previously, Robert Hazlett worked at BTIG.
Robert Hazlett’s has documented 126 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CMPS, Compass Pathways Plc at 24-Jun-2025.
Analyst best performing recommendations are on AXSM (AXSOME THERAPEUTICS).
The best stock recommendation documented was for AXSM (AXSOME THERAPEUTICS) at 12/17/2019. The price target of $97 was fulfilled within 3 days with a profit of $16.03 (19.8%) receiving and performance score of 65.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Feb-2025
$132
$0.13 (0.10%)
$132
1 years ago
(28-Feb-2025)
12/14 (85.71%)
$3.8 (2.96%)
738
Hold Since 24-Feb-2025
$132
$0.13 (0.10%)
$100
1 years 4 days ago
(24-Feb-2025)
11/12 (91.67%)
$3.43 (2.67%)
269
Hold Since 13-Jan-2025
$100
1 years 7 days ago
(21-Feb-2025)
21/22 (95.45%)
$-27.19 (-21.38%)
170
Hold Since 25-Jun-2024
$132
$0.13 (0.10%)
$87
1 years 23 days ago
(05-Feb-2025)
8/9 (88.89%)
$4.97 (3.91%)
221
Buy Since 26-Feb-2018
$132
$0.13 (0.10%)
$89
1 years 1 months 1 days ago
(27-Jan-2025)
11/12 (91.67%)
$4.79 (3.77%)
39
What Year was the first public recommendation made by Robert Hazlett?
